Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ARYE Stock Summary
In the News
ARYE Financial details
Company Rating
Buy
Market Cap
198.77M
Income
6.8M
Revenue
0
Book val./share
7.72
Cash/share
0.02
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
29.24
Forward P/E
-
PEG
0
P/S
-
P/B
1.34
P/C
-
P/FCF
-487.49
Quick Ratio
0.1
Current Ratio
0.14
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-50.3M
EPS next Y
-
EPS next Q
-
EPS this Y
-686.67%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-100%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
71.17%
Inst Trans
0.94%
ROA
4%
ROE
5%
ROC
-0.01%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
9.7-10.5
52W High
-
52W Low
-
RSI
-
Rel Volume
0.01
Avg Volume
47.1K
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
-
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-
ARYE Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2021-12-31 | 2022-12-31 |
---|---|---|---|
2.02K | 2.02K | ||
Revenue per share | 0 | 0 | |
Net income per share | -0.15 | 0.88 | |
Operating cash flow per share | -0.04 | -0.1 | |
Free cash flow per share | -0.04 | -0.1 | |
Cash per share | 0.04 | 0.1 | |
Book value per share | 7.44 | 39.24 | |
Tangible book value per share | 7.44 | 39.24 | |
Share holders equity per share | 7.44 | 39.24 | |
Interest debt per share | 0 | -0.55 | |
Market cap | 186.11M | 37.71M | |
Enterprise value | 185.33M | 37.33M | |
P/E ratio | -62.94 | 11.48 | |
Price to sales ratio | 0 | 0 | |
POCF ratio | -223.94 | -96.52 | |
PFCF ratio | -223.94 | -96.52 | |
P/B Ratio | 1.3 | 0.26 | |
PTB ratio | 1.3 | 0.26 | |
EV to sales | 0 | 0 | |
Enterprise value over EBITDA | -62.04 | -43.6 | |
EV to operating cash flow | -223 | -95.54 | |
EV to free cash flow | -223 | -95.54 | |
Earnings yield | -0.02 | 0.09 | |
Free cash flow yield | 0 | -0.01 | |
Debt to equity | 0 | 0 | |
Debt to assets | 0 | 0 | |
Net debt to EBITDA | 0.26 | 0.45 | |
Current ratio | 0.46 | 0.19 | |
Interest coverage | 98.9 | 0.41 | |
Income quality | 0.28 | -0.32 | |
Dividend Yield | 0 | 0 | |
Payout ratio | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | |
Research and developement to revenue | 0 | 0 | |
Intangibles to total assets | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | |
Capex to revenue | 0 | 0 | |
Capex to depreciation | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | |
Graham number | 5.08 | 27.86 | |
ROIC | -0.02 | -0.02 | |
Return on tangible assets | -0.02 | 0.02 | |
Graham Net | -0.37 | -1.37 | |
Working capital | -1.48M | -2.34M | |
Tangible asset value | 142.82M | 146.65M | |
Net current asset value | -6.71M | -4.95M | |
Invested capital | 0 | 0 | |
Average receivables | 0 | 0 | |
Average payables | 0 | 12.06K | |
Average inventory | 0 | 0 | |
Days sales outstanding | 0 | 0 | |
Days payables outstanding | 0 | 0 | |
Days of inventory on hand | 0 | 0 | |
Receivables turnover | 0 | 0 | |
Payables turnover | 0 | 0 | |
Inventory turnover | 0 | 0 | |
ROE | -0.02 | 0.02 | |
Capex per share | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-03-31 for Q1
Metric | History | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | -0.02 | 0.01 | 0.33 | -50.3M | 0.17 | |
Operating cash flow per share | 0 | -0.01 | -0.01 | -566.52K | 0 | |
Free cash flow per share | 0 | -0.01 | -0.01 | -566.52K | 0 | |
Cash per share | 0.04 | 0.03 | 0.02 | 6.42M | 0.02 | |
Book value per share | 7.43 | 7.43 | 7.59 | 2.44B | 7.72 | |
Tangible book value per share | 7.43 | 7.43 | 7.59 | 2.44B | 7.72 | |
Share holders equity per share | 7.43 | 7.43 | 7.59 | 2.44B | 7.72 | |
Interest debt per share | 0.01 | -0.02 | -0.21 | 57.77M | -0.09 | |
Market cap | 186.3M | 186.49M | 188.22M | 0.61 | 196.28M | |
Enterprise value | 185.6M | 185.96M | 187.8M | -385.19K | 195.98M | |
P/E ratio | -142.09 | 195.3 | 7.36 | 0 | 15.42 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | -2.58K | -1.08K | -1.68K | 0 | -2.2K | |
PFCF ratio | -2.58K | -1.08K | -1.68K | 0 | -2.2K | |
P/B Ratio | 1.31 | 1.31 | 1.29 | 0 | 1.32 | |
PTB ratio | 1.31 | 1.31 | 1.29 | 0 | 1.32 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | -1.04K | -392.69 | -227.66 | 1.69 | -103.45 | |
EV to operating cash flow | -2.57K | -1.08K | -1.68K | 11.33 | -2.2K | |
EV to free cash flow | -2.57K | -1.08K | -1.68K | 11.33 | -2.2K | |
Earnings yield | 0 | 0 | 0.03 | -4.98M | 0.02 | |
Free cash flow yield | 0 | 0 | 0 | -56.15K | 0 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | 3.93 | 1.12 | 0.51 | 1.69 | 0.16 | |
Current ratio | 0.4 | 0.31 | 0.24 | 0.19 | 0.14 | |
Interest coverage | -2.3 | 0.5 | 0.04 | -0.07 | 0.12 | |
Income quality | 0.26 | -132.64 | -0.04 | 0.02 | -0.06 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 1.69 | 1.44 | 7.54 | 1.66B | 5.37 | |
ROIC | 0 | -0.3 | 0 | 0 | 0 | |
Return on tangible assets | 0 | 0 | 0.04 | -0.02 | 0.02 | |
Graham Net | -0.38 | -0.39 | -0.26 | -85.15M | -0.28 | |
Working capital | -1.71M | -1.94M | -2.11M | -2.34M | -2.54M | |
Tangible asset value | 142.54M | 142.54M | 145.66M | 146.65M | 148.14M | |
Net current asset value | -6.94M | -7.18M | -4.72M | -4.95M | -5.15M | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 33.96K | 33.85K | 12.59K | 12.1K | 12.22K | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0 | 0 | 0.04 | -0.02 | 0.02 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
ARYE Frequently Asked Questions
What is ARYA Sciences Acquisition Corp V stock symbol ?
ARYA Sciences Acquisition Corp V is a US stock , located in New york of Ny and trading under the symbol ARYE
What is ARYA Sciences Acquisition Corp V stock quote today ?
ARYA Sciences Acquisition Corp V stock price is $- today.
Is ARYA Sciences Acquisition Corp V stock public?
Yes, ARYA Sciences Acquisition Corp V is a publicly traded company.